# Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference
Canonical URL: https://biopharmsignal.com/news/AXGN/axogen-inc-to-participate-in-the-2026-bank-of-america-global-healthcare-conference
Ticker: AXGN
Company: AxoGen
Source: AxoGen
Published: 2026-04-30 11:00 EST
Original Source URL: https://ir.axogeninc.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-07-15 11:00 EST — [Axogen, Inc. to Report Second Quarter 2026 Financial Results on July 29, 2026](https://biopharmsignal.com/news/AXGN/axogen-inc-to-report-second-quarter-2026-financial-results-on-july-29-2026-56aa71ab) — Source: AxoGen
- 2026-04-30 11:00 EST — [Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference](https://biopharmsignal.com/news/AXGN/axogen-inc-to-participate-in-the-2026-bank-of-america-global-healthcare-conference) — Source: AxoGen
- 2026-04-28 11:00 EST — [Axogen, Inc. Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/AXGN/axogen-inc-reports-first-quarter-2026-financial-results) — Source: AxoGen
- 2026-04-14 11:00 EST — [Axogen, Inc. to Report First Quarter 2026 Financial Results on April 28, 2026](https://biopharmsignal.com/news/AXGN/axogen-inc-to-report-first-quarter-2026-financial-results-on-april-28-2026) — Source: AxoGen
- 2026-02-24 12:00 EST — [Axogen, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results](https://biopharmsignal.com/news/AXGN/axogen-inc-reports-fourth-quarter-and-full-year-2025-financial-results) — Source: AxoGen
## Related News
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)
- 2026-07-21 11:30 EST — ABEO — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)